Palvella Therapeutics to Host Third Quarter 2025 Financial Results and Corporate Update Conference Call on November 11, 2025
Palvella Therapeutics (Nasdaq: PVLA) will report third quarter 2025 financial results before market open on Tuesday, November 11, 2025. Management will host a conference call for investors at 8:30 a.m. ET the same day to discuss results and provide a corporate update.
A live webcast with slides will be available via the company's Events & Presentations page and a phone registration link will supply dial-in details. A replay of the webcast will be posted approximately 2 hours after the call and will be archived for 90 days at www.palvellatx.com.
Palvella Therapeutics (Nasdaq: PVLA) riporterà i risultati finanziari del terzo trimestre 2025 prima dell'apertura del mercato di martedì 11 novembre 2025. La direzione terrà una conference call per gli investitori alle 8:30 ET nella stessa giornata per discutere i risultati e fornire un aggiornamento aziendale.
Una webcast in diretta con diapositive sarà disponibile tramite la pagina Events & Presentations dell'azienda e un link di registrazione telefonica fornirà i dettagli per la chiamata. Una replica della webcast sarà pubblicata circa 2 ore dopo la chiamata e sarà archiviata per 90 giorni su www.palvellatx.com.
Palvella Therapeutics (Nasdaq: PVLA) reportará los resultados del tercer trimestre de 2025 antes de la apertura del mercado el martes 11 de noviembre de 2025. La dirección organizará una conference call para inversionistas a las 8:30 a.m. ET el mismo día para discutir los resultados y proporcionar una actualización corporativa.
Una webcast en vivo con diapositivas estará disponible a través de la página de Events & Presentations de la empresa y un enlace de registro telefónico proporcionará los detalles para marcar. Una reproducción del webcast estará disponible aproximadamente 2 horas después de la llamada y estará archivada por 90 días en www.palvellatx.com.
Palvella Therapeutics (Nasdaq: PVLA)는 2025년 3분기 재무 실적을 미 증시 개장 전에 발표할 예정이며, 2025년 11월 11일 화요일에 발표합니다. 경영진은 같은 날 동부 표준시 8:30에 투자자들을 위한 컨퍼런스 콜을 주최하여 결과를 논의하고 기업 업데이트를 제공할 예정입니다.
생방송 웹캐스트와 슬라이드가 회사의 Events & Presentations 페이지를 통해 제공되며, 전화 등록 링크를 통해 다이얼 인 정보를 얻을 수 있습니다. 콜 후 약 2시간 정도의 재생이 게시되며, 90일 동안 보관됩니다 www.palvellatx.com.
Palvella Therapeutics (Nasdaq : PVLA) publiera les résultats financiers du troisième trimestre 2025 avant l’ouverture du marché le mardi 11 novembre 2025. La direction organisera une conférence téléphonique pour les investisseurs à 8h30 HAE le même jour pour discuter des résultats et fournir une mise à jour de l’entreprise.
Une webdiffusion en direct avec des diapositives sera disponible via la page Events & Presentations de l’entreprise et un lien d’inscription téléphonique fournira les détails pour composer le numéro. Une rediffusion de la webdiffusion sera publiée environ 2 heures après l’appel et sera archivée pendant 90 jours sur www.palvellatx.com.
Palvella Therapeutics (Nasdaq: PVLA) wird die Finanzergebnisse für das dritte Quartal 2025 vor Handelsbeginn am Dienstag, dem 11. November 2025 berichten. Das Management wird am selben Tag eine Investoren-Konferenzschaltung um 8:30 Uhr ET ausrichten, um die Ergebnisse zu besprechen und ein Unternehmensupdate zu geben.
Eine Live-Webcast mit Folien wird über die Unternehmensseite Events & Presentations verfügbar sein, und ein Telefon-Registrierungslink wird die Dial-in-Details bereitstellen. Eine Wiedergabe des Webcasts wird etwa 2 Stunden nach der Call veröffentlicht und wird für 90 Tage unter www.palvellatx.com archiviert.
Palvella Therapeutics ( Nasdaq: PVLA ) ستعلن عن نتائج الربع الثالث من عام 2025 قبل افتتاح السوق في الثلاثاء 11 نوفمبر 2025. ستعقد الإدارة مكالمة مؤتمر للمستثمرين في الساعة 8:30 صباحاً بتوقيت شرق الولايات المتحدة في اليوم نفسه لمناقشة النتائج وتقديم تحديث مؤسسي.
سيكون هناك بث مباشر عبر الويب مع شرائح متاحة عبر صفحة الشركة Events & Presentations وسيقدم رابط التسجيل الهاتفي تفاصيل الانضمام. سيتم نشر إعادة للبث عبر الويب لمدة حوالي 2 ساعة بعد الاتصال وسيتم أرشفته لمدة 90 يوماً على www.palvellatx.com.
- None.
- None.
WAYNE, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases for which there are no FDA-approved therapies, today announced that it will report its third quarter 2025 financial results before market open on Tuesday, November 11, 2025. Palvella management will host a conference call for investors at 8:30 a.m. ET on that same day to discuss the results and provide a corporate update.
To access the live webcast of the call with slides, please click here or visit the "Events & Presentations" section of Palvella’s website. To access the call by phone, please use this registration link, and you will be provided with dial in details. A replay of the webcast will be available approximately 2 hours after the conclusion of the call and archived for 90 days under the "Events & Presentations" section of the Company's website at www.palvellatx.com.
About Palvella Therapeutics
Founded and led by rare disease drug development veterans, Palvella Therapeutics, Inc. (Nasdaq: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases for which there are no FDA-approved therapies. Palvella is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Palvella’s lead product candidate, QTORIN
QTORIN™ rapamycin is for investigational use only and has not been approved or cleared by the FDA or by any other regulatory agency for any indication.
Contact Information
Investors
Wesley H. Kaupinen
Founder and CEO, Palvella Therapeutics
wes.kaupinen@palvellatx.com
Media
Marcy Nanus
Managing Partner, Trilon Advisors, LLC
mnanus@trilonadvisors.com
FAQ
When will Palvella (PVLA) announce its Q3 2025 results?
What time is the Palvella (PVLA) Q3 2025 conference call?
How can I listen to the Palvella (PVLA) Q3 2025 webcast and view slides?
Can I join the Palvella (PVLA) call by phone and how do I get dial-in details?
When will the replay of the Palvella (PVLA) Q3 2025 call be available and for how long?
Where can investors find the Palvella (PVLA) conference call slides after the event?
